The world's first glucose magnet
For the first time, glucose can be tracked by drawing the body’s fluid through skin using tiny magnetic forces — a breakthrough in magneto-hydrodynamics. The result is continuous insight into your glucose levels with no needles under your skin.
Glucose monitoring that adapts to how diabetes really behaves
Diabetes isn’t static – it changes over time based on lifestyle choices, genetics and age. For most people with Type 2 diabetes, those shifts don’t require 24/7 monitoring — just clarity in the moments when you need it.
At times you may want closer follow-ups; at others, only periodic insight into your time in range — something fingersticks don’t provide. Your monitoring should adapt to these phases, not force a one-size-fits-all approach.
Sofio is built around this principle.
Two parts, in sync with you
Sofio’s modular design combines a long-lasting transmitter with a gentle, replaceable sensor. This keeps the system flexible and accessible – letting you choose your own wear rhythm instead of being locked into long, fixed sensor cycles. Use Sofio during the days or weeks you need more insight, and set it aside when you’re stable.
The same transmitter lasts for up to two years — you’ll replace only the soft sensor with each wear, for clear, one-day glucose insights when you need them.
Get rapid results.
Automatic readings, clear insights, and personalised glucose targets — all visible at a glance.
How does it work?
Sofio’s patented technology uses magneto-hydrodynamics to gently draw a micro-sample of interstitial fluid from your skin – without using needles. The glucose levels in the fluid are then analysed using well established glucose electrochemical biosensors.
Did you know?
no text
Over 500 million people live with Type 2 diabetes.
Half of them don’t know it.
Diabetes progresses quietly.
Damaging changes can begin years before symptoms appear.
For many, the first step is simply getting clarity.
Sofio makes the invisible visible.
Simple, flexible and accessible glucose awareness.
Designed for people with Type 2 diabetes and others who manage their glucose without intensive insulin use.
